Cargando…
Programmed cell death in alcohol-associated liver disease
Alcohol-associated liver disease (ALD), which ranges from mild disease to alcohol-associated hepatitis and cirrhosis, is the most prevalent type of chronic liver disease and a leading cause of morbidity and mortality worldwide. Accumulating evidence reveals that programmed cell death (PCD) plays a c...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641549/ https://www.ncbi.nlm.nih.gov/pubmed/32951412 http://dx.doi.org/10.3350/cmh.2020.0142 |
_version_ | 1783605939031506944 |
---|---|
author | Miyata, Tatsunori Nagy, Laura E. |
author_facet | Miyata, Tatsunori Nagy, Laura E. |
author_sort | Miyata, Tatsunori |
collection | PubMed |
description | Alcohol-associated liver disease (ALD), which ranges from mild disease to alcohol-associated hepatitis and cirrhosis, is the most prevalent type of chronic liver disease and a leading cause of morbidity and mortality worldwide. Accumulating evidence reveals that programmed cell death (PCD) plays a crucial role in progression of ALD involving crosstalk between hepatocytes and immune cells. Multiple pathways of PCD, including apoptosis, necroptosis, autophagy, pyroptosis and ferroptosis, are reported in ALD. Interestingly, PCD pathways are intimately linked and interdependent, making it difficult to therapeutically target a single pathway. This review clarifies the multiple types of PCD occurring in liver and focuses on crosstalk between hepatocytes and innate immune cells in ALD. |
format | Online Article Text |
id | pubmed-7641549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Korean Association for the Study of the Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-76415492020-11-13 Programmed cell death in alcohol-associated liver disease Miyata, Tatsunori Nagy, Laura E. Clin Mol Hepatol Review Alcohol-associated liver disease (ALD), which ranges from mild disease to alcohol-associated hepatitis and cirrhosis, is the most prevalent type of chronic liver disease and a leading cause of morbidity and mortality worldwide. Accumulating evidence reveals that programmed cell death (PCD) plays a crucial role in progression of ALD involving crosstalk between hepatocytes and immune cells. Multiple pathways of PCD, including apoptosis, necroptosis, autophagy, pyroptosis and ferroptosis, are reported in ALD. Interestingly, PCD pathways are intimately linked and interdependent, making it difficult to therapeutically target a single pathway. This review clarifies the multiple types of PCD occurring in liver and focuses on crosstalk between hepatocytes and innate immune cells in ALD. The Korean Association for the Study of the Liver 2020-10 2020-09-21 /pmc/articles/PMC7641549/ /pubmed/32951412 http://dx.doi.org/10.3350/cmh.2020.0142 Text en Copyright © 2020 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Miyata, Tatsunori Nagy, Laura E. Programmed cell death in alcohol-associated liver disease |
title | Programmed cell death in alcohol-associated liver disease |
title_full | Programmed cell death in alcohol-associated liver disease |
title_fullStr | Programmed cell death in alcohol-associated liver disease |
title_full_unstemmed | Programmed cell death in alcohol-associated liver disease |
title_short | Programmed cell death in alcohol-associated liver disease |
title_sort | programmed cell death in alcohol-associated liver disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641549/ https://www.ncbi.nlm.nih.gov/pubmed/32951412 http://dx.doi.org/10.3350/cmh.2020.0142 |
work_keys_str_mv | AT miyatatatsunori programmedcelldeathinalcoholassociatedliverdisease AT nagylaurae programmedcelldeathinalcoholassociatedliverdisease |